← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 20, 2022Last known activity
Jun 5, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (4 own, 0 via acquisition)
Recent trials (12)
- NCT07192081Lead sponsorN/AJun 5, 2025
- NCT07192081Sponsor investigatorN/AJun 5, 2025
- NCT06662175Sponsor investigatorPhase 2/Phase 3Nov 30, 2024
- NCT06662175Lead sponsorPhase 2/Phase 3Nov 30, 2024
- NCT06021990OfficialPhase 3Oct 1, 2023
- NCT06021990Lead sponsorPhase 3Oct 1, 2023
- NCT06021990Reponsible party - principal investigatorPhase 3Oct 1, 2023
- NCT06021990Study chairPhase 3Oct 1, 2023
- NCT06021990Sponsor investigatorPhase 3Oct 1, 2023
- NCT05255848Reponsible party - principal investigatorPhase 2/Phase 3Jun 20, 2022
- NCT05255848Lead sponsorPhase 2/Phase 3Jun 20, 2022
- NCT05255848Sponsor investigatorPhase 2/Phase 3Jun 20, 2022
Details
- Last known activity
- Jun 5, 2025